Pureims B.V.
- Home
- Companies
- Pureims B.V.
- Articles
1 Article found
Pureims B.V. articles
Introduction
Intramuscular administration of epinephrine by autoinjectors is prone to errors and associated with a high barrier to use.1-3
This puts patients at risk of untimely treatment of allergic reactions, which increases the chance of anaphylaxis.1-3
Epinephrine dry powder inhalation offers a more convenient, low-barrier alternative to autoinjectors, thereby preventing the occurrence of anaphylaxis due to untimely treatment
Nov. 28, 2022
Floris Grasmeijer;Wouter Dijkstra;Marcel Hoppentocht;Paul Hagedoorn;Erik Frijlink
